Trinity Point Wealth, LLC Abbott Laboratories Transaction History

Trinity Point Wealth, LLC

$680 Million
Q3 2024

A detailed history of Trinity Point Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 23,308 shares of ABT stock, worth $3 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

23,308

Previous 23,310 0.01%

Holding current value

$3 Million

Previous $2.42 Million 9.7%

% of portfolio

0.39%

Previous 0.39%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $200 - $236	-2 Reduced 0.01%	23,308 $2.66 Million
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $141,424 - $157,865	1,404 Added 6.41%	23,310 $2.42 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $72,173 - $79,712	659 Added 3.1%	21,906 $2.49 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $33,911 - $41,510	376 Added 1.8%	21,247 $2.34 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $30,283 - $36,334	317 Added 1.54%	20,871 $2.02 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $141,192 - $157,318	1,401 Added 7.31%	20,554 $2.24 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $27,605 - $32,492	285 Added 1.51%	19,153 $1.94 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $100,193 - $117,542	1,054 Added 5.92%	18,868 $2.07 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $55,540 - $64,305	574 Added 3.33%	17,814 $1.72 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $4,389 - $5,304	-43 Reduced 0.25%	17,240 $1.87 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $4,674 - $5,700	41 Added 0.24%	17,283 $2.05 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $12,939 - $15,843	112 Added 0.65%	17,242 $2.43 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $1,283 - $1,419	-11 Reduced 0.06%	17,130 $2.02 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $17,772 - $20,921	168 Added 0.99%	17,141 $1.99 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $26,339 - $31,031	-242 Reduced 1.41%	16,973 $2.03 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $222,390 - $242,341	2,118 Added 14.03%	17,215 $1.98 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $57,458 - $69,778	-627 Reduced 3.99%	15,097 $1.64 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $47,856 - $61,250	-625 Reduced 3.82%	15,724 $1.44 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $43,345 - $63,383	-690 Reduced 4.05%	16,349 $1.29 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $117,372 - $130,663	-1,495 Reduced 8.07%	17,039 $1.48 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $867,176 - $940,289	10,596 Added 133.48%	18,534 $1.52 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $72,515 - $84,575	-995 Reduced 11.14%	7,938 $703,000
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $338,847 - $409,667	5,117 Added 134.09%	8,933 $714,000
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $250,176 - $283,414	3,816 New	3,816 $276,000

Others Institutions Holding ABT

# of Institutions

3,217

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.

Account

Trinity Point Wealth, LLC Abbott Laboratories Transaction History